Back    Zoom +    Zoom -
<Research>Macquarie Ratings, TPs on CN CDMOs & Biotechs (Table)
Recommend
33
Positive
45
Negative
15
Shares | Ratings | Target prices (HK$)

BEIGENE (06160.HK) | Outperform | 182
HANSOH PHARMA (03692.HK) | Outperform | 22.9
AKESO (09926.HK) | Outperform | 80
INNOVENT BIO (01801.HK) | Neutral -> Underperform | 35
WUXI BIO (02269.HK) | Neutral | 27
WUXI APPTEC (02359.HK) | Neutral | 70
WUXI XDC (02268.HK) | Outperform | 48
ASYMCHEM (06821.HK) | Neutral | 56
PHARMARON (03759.HK) | Underperform | 11
CSPC PHARMA (01093.HK) | Neutral | 5
SINO BIOPHARM (01177.HK) | Outperform | 4.1

Related NewsMacquarie Prefers Biotechs Over CDMOs; Top Picks BEIGENE/ AKESO

AAStocks Financial News